The Medicine Control Authority of Zimbabwe (MCAZ) has said 96 people experienced mild or severe reactions to Covid-19 vaccines.
According to an update by the Ministry of Health and Child Care released on 2 October, over 5 million people had received COVID-19 vaccines and 96 of them had experenced side effects.
Meanwhile, authorities are investigating two deaths that have been linked to adverse reactions to the vaccines, while two other suspected cases of deaths following vaccination have been deemed coincidental.
Experts found no evidence to conclude that the deaths were caused by vaccines.
According to MCAZ, the most common cases of Adverse Events Following Immunisation (AEFI) included headaches, dizziness and fatigue among other non-serious episodes of discomfort.
Health experts define an adverse effect as serious when it results in hospitalisation, extended stay in hospital, a significant reduction in functional capacity, or death.
Responding to questions from The Sunday Mail, MCAZ projects and public relations officer, Mr Shingai Gwatidzo, said the majority of those with suspected AEFIs have recovered.
Out of a cumulative total of 3,06 million first dose and 2,30 million second dose of Covid-19 vaccines, the authority received a total of 96 suspected cases AEFIs.
The majority of the AEFIs were non-serious and were consistent with the safety profile of the vaccines as was determined from the clinical studies conducted by the vaccine developers, that is headache, dizziness, fatigue, general body weakness, itchy skin, itch rash, chills, sore throat, runny nose, blocked nose, sneezing, nausea, injection site pain, numbness of the injected arm and chests pains.
The authority received four suspected AEFIs resulting in death following vaccination.
A few serious illnesses were also reported and these included seizures, strokes, angioedema and deep vein thrombosis.
Mr Gwatidzo said 70 cases were recorded from those who had received the Sinopharm vaccine, while 25 had been administered the Sinovac vaccine and the other one was not specified.
More: The Sunday Mail